Tag: life sciences
-

Biotech to Synthesize Proteins in Microgravity
A biotechnology company synthesizing pure proteins from DNA is preparing to test its process in weightless conditions on the International Space Station.
-

NIH Award Funds A.I. to Detect Alzheimer’s in Clinical Notes
A small-business grant to a developer of natural language analytics for health care aims to detect evidence of cognitive decline from physicians’ notes in electronic health records.
-

Bio-Electric Regeneration Company Adds $8M in Seed Funds
A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds.
-

Biotech Drug Shown to Kill Prostate Tumor Cells
Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue.
-

Nasal Spray Reduces Flu Duration in Challenge Trial
An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus.
-

Clinical Trial Underway Testing Influenza Vaccine Patch
A clinical trial has begun testing a commercially-available flu vaccine administered with a painless patch device against conventional syringe injection delivery.
-

Data Support Placebo Group Alternatives in Rare Disease Trials
Findings from a review of medical data and records indicate matched genetic control groups may not be needed in clinical trials testing treatments for Duchenne muscular dystrophy.
-

AI-Aided Mobile App Shown to Screen for Melanoma
The developer of an app using algorithms to analyze images of skin lesions says clinical trial findings show the system detects melanoma more reliably than some physicians.
-

Allergy Antibody Biotech Gains $40M in New Funds
A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round.
-

Start-Up Creating Software to Simplify Biomedical Analytics
A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data.